HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francisco Garcia Soriano Selected Research

Hypertonic Saline Solution

1/2013Hypertonic saline solution drives neutrophil from bystander organ to infectious site in polymicrobial sepsis: a cecal ligation and puncture model.
12/2012Volume replacement with saline solutions during pancreatitis in rats and the hepatic profiles of apoptotic proteins and heat-shock proteins.
9/2008Sepsis volume reposition with hypertonic saline solution.
2/2007Hypertonic saline solution increases the expression of heat shock protein 70 and improves lung inflammation early after reperfusion in a rodent model of controlled hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francisco Garcia Soriano Research Topics

Disease

23Sepsis (Septicemia)
01/2022 - 04/2002
9Inflammation (Inflammations)
10/2022 - 04/2002
7Septic Shock (Toxic Shock Syndrome)
01/2022 - 03/2008
6Endotoxemia
01/2021 - 10/2010
5Lung Injury
12/2015 - 07/2009
4Shock
01/2019 - 05/2002
4Ischemia
02/2016 - 10/2002
3Reperfusion Injury
02/2016 - 04/2002
3Critical Illness (Critically Ill)
06/2011 - 03/2006
3Necrosis
03/2006 - 04/2002
2Hemorrhage
01/2019 - 02/2007
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2015 - 05/2003
2Pneumonia (Pneumonitis)
12/2015 - 02/2007
2Acute Lung Injury
12/2015 - 01/2006
2Infections
07/2014 - 03/2006
2Pancreatitis
12/2012 - 07/2009
2Bacterial Infections (Bacterial Infection)
06/2011 - 01/2009
1Obesity
10/2022
1Hepatitis
12/2021
1Ischemic Stroke
12/2021
1Neuroinflammatory Diseases
12/2021
1Multiple Organ Failure (MODS)
12/2021
1Neoplasms (Cancer)
12/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Atherosclerosis
01/2021
1Pulmonary Emphysema
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Leptospirosis
01/2019
1Atrophy
01/2019
1Edema (Dropsy)
02/2016
1Pulmonary Edema
02/2016
1Brain Ischemia (Cerebral Ischemia)
02/2016
1Heart Failure
01/2016
1Fibrosis (Cirrhosis)
11/2014
1Body Weight (Weight, Body)
07/2014
1Bruton type agammaglobulinemia
05/2013
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
10/2012

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
10/2022 - 04/2002
6LipopolysaccharidesIBA
02/2017 - 05/2002
5Oxidants (Oxidizing Agents)IBA
06/2011 - 04/2002
4Interleukin-6 (Interleukin 6)IBA
10/2022 - 04/2002
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022 - 04/2002
4Saline SolutionIBA
02/2017 - 12/2012
4Hypertonic Saline SolutionIBA
01/2013 - 02/2007
3olaparibIBA
01/2022 - 01/2019
3Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 02/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 04/2002
3Proteins (Proteins, Gene)FDA Link
02/2017 - 12/2012
3Interleukin-10 (Interleukin 10)IBA
05/2013 - 04/2002
3Peroxynitrous Acid (Peroxynitrite)IBA
06/2011 - 05/2002
2Messenger RNA (mRNA)IBA
10/2022 - 10/2010
2Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 01/2009
2Gastrin-Releasing PeptideIBA
10/2012 - 01/2006
2Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA
10/2012 - 01/2006
2Bombesin Receptors (Bombesin Receptor)IBA
10/2012 - 01/2006
2Oxygen (Dioxygen)IBA
05/2012 - 09/2010
2Superoxides (Superoxide)IBA
06/2011 - 09/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2011 - 09/2010
2HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
07/2009 - 02/2007
2LipidsIBA
01/2008 - 03/2006
2EmulsionsIBA
01/2008 - 03/2006
2Fatty Acids (Saturated Fatty Acids)IBA
01/2008 - 03/2006
2EnzymesIBA
05/2002 - 04/2002
2N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA
05/2002 - 02/2002
1ResistinIBA
10/2022
1NAD (NADH)IBA
12/2021
1Pancreatic Elastase (Elastase)IBA
01/2021
1Lipoproteins (Lipoprotein)IBA
01/2021
1Cholesterol Ester Transfer ProteinsIBA
01/2021
1Vitamin DFDA LinkGeneric
01/2020
1InterleukinsIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1Hypertonic SolutionsIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1AntigensIBA
01/2019
1Caspase 3 (Caspase-3)IBA
01/2019
1pristane (pristan)IBA
01/2019
1Telomerase (Telomerase Reverse Transcriptase)IBA
02/2017
1CreatineIBA
02/2016
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2016
1Metalloproteases (Metalloproteinases)IBA
12/2015
1CollagenIBA
12/2015
1Cytidine Diphosphate (CDP)IBA
11/2014
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2014
1salicylhydroxamic acid (SHAM)IBA
07/2014
1Immunoglobulin M (IgM)IBA
05/2013
1Agammaglobulinaemia Tyrosine KinaseIBA
05/2013
1Caspase 2IBA
12/2012
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2012
1Taurocholic Acid (Sodium Taurocholate)IBA
12/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
10/2012
1Toll-Like Receptor 4IBA
10/2012

Therapy/Procedure

6Ligation
01/2019 - 04/2002
6Punctures
01/2019 - 04/2002
5Therapeutics
12/2021 - 10/2002
3Resuscitation
12/2015 - 10/2002
2Investigational Therapies (Experimental Therapy)
01/2022 - 01/2019
1Artificial Respiration (Mechanical Ventilation)
01/2019
1Splenectomy
01/2019
1Nutrition Therapy (Medical Nutrition Therapy)
09/2015